Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Biologics Safety Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service , By Application, By Test Type, By Region, Segment Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.
The global biologics safety testing market size is expected to reach USD 11,949.49 million by 2032, according to a new study.
The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market for biologics safety testing requires stringent regulatory requirements, and agencies like (EMA) and the (FDA) demand that biologics undergo extensive effectiveness and safety testing before receiving marketing authorization, positively influencing the market growth.
The FDA has issued guidelines for various processes in biologics development like administrative guidelines, adverse effects, product derivation guidelines, application submission guidelines, clinical trials guidelines, CMC and GMP guidelines, Devices guidelines, and Labeling and Promotion guidelines.
New biologics are being developed due to increased investment in R&D in the pharmaceutical and healthcare sectors, which has augmented market growth. For instance, in December 2022, Global pharma companies GSK, Takeda, and Sanofi announced their collaboration with the agency for the National University of Singapore; Nanyang Technological University, & the Singapore Institute of Technology to expand country's capacity for producing biologics.
The increasing trend towards personalized medicine and targeted therapies has led to the development of biologics tailored to specific patient populations, increasing the demand for biologics safety testing. The global biologics market is growing rapidly, which is expected to continue in the coming years, augmenting biologics safety testing. In November 2022, Abzena launched a new biologics testing facility in California. The facility enables stricter control over schedules and a thorough review of each integrated program to give appropriate biosafety data de-risking and their partners' activities and assist with regulatory filings.
Market Dynamics
Drivers and Opportunities
- Development of New and Advanced Instruments for Biologics Testing
- Increasing Investment in Research and Development in the Pharmaceutical and Biotechnology Industries
Restraints and Challenges
- High Cost of Biologics
Biologics Safety Testing Market Report Highlights
- Consumables segment is leading the global market owing to the growing use of biologics drugs due to growing prevalence of the chronic diseases.
- Vaccine development segment is expected to grow at a high CAGR during the forecast period. The rising demand for the vaccines due to Covid-19 and other diseases is bolstering market growth.
- Endotoxin test segment accounted for the largest market share in 2022 due to an increase in demand for innovative medical equipment, medicinal medicines, and biologics to perform many tests.
- North America is the largest market due to the presence of many small and large players in the region.
- Key players include Charles River Laboratories, Thermo Fisher Scientific, SGS and Bioservice Scientific Laboratories.
The publisher has segmented the Biologics Safety Testing market report according to test type, product & services, application, and region:
Biologics Safety Testing, Test Type Outlook (Revenue - USD Million, 2019 - 2032)
- Endotoxin Test
- Sterility Test
- Mycoplasma Tests
- Bioburden Tests
- Residual Host-cell Proteins and DNA Detection Tests
- Virus safety Test
- Others
Biologics Safety Testing, Product & Services Outlook (Revenue - USD Million, 2019 - 2032)
- Consumables
- Instrument
- Services
Biologics Safety Testing, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Vaccine Development & Manufacturing
- Monoclonal Antibodies Development & Manufacturing
- Cellular & Gene Therapy
- Blood & Blood related Products Development and Manufacturing
- Others
Biologics Safety Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 116 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value (USD) in 2023 | $4169.72 million |
| Forecasted Market Value (USD) by 2032 | $11949.49 million |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Biologics Safety Testing Market Insights
5. Global Biologics Safety Testing Market, by Test Type
5.1. Key Findings
5.2. Introduction
5.3. Endotoxin Test
5.4. Sterility Test
5.5. Mycoplasma Tests
5.6. Bioburden Tests
5.7. Residual Host-cell Proteins & DNA Detection Tests
5.8. Virus safety Test
5.9. Others
6. Global Biologics Safety Testing Market, by Application
6.1. Key Findings
6.2. Introduction
6.3. Vaccine Development and Manufacturing
6.4. Monoclonal Antibodies Development and Manufacturing
6.5. Cellular & Gene Therapy Products Development and Manufacturing
6.6. Blood and Blood Products Development and Manufacturing
6.7. Other Application
7. Global Biologics Safety Testing Market, by Product & Services
7.1. Key Findings
7.2. Introduction
7.3. Consumables
7.4. Instrument
7.5. Services
8. Global Biologics Safety Testing Market, by Geography
9. Competitive Landscape
10. Company Profiles
Companies Mentioned
- Avance Biosciences
- Charles River Laboratories
- Thermo Fisher Scientific
- Merck KGaA
- Creative Biogene
- Eurofins Scientific
- Lonza Group AG
- Maravai LifeSciences
- WuXi AppTec
- Pace Analytical Services Inc.
- Eurofins Scientific
For more information about this report visit https://www.researchandmarkets.com/r/qwdgaj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
